We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Prothena Corp
PRTA
$449M
| $2M | 0.01% |
200,000
+175,000
| +700% | +$2.11M |
|
702
APA Corp
APA
$12.9B
| $1.96M | ﹤0.01% |
+206,415
| New | +$2.83M |
|
703
News Corp Class B
NWS
$18.3B
| $1.9M | ﹤0.01% |
136,182
-3,756
| -3% | -$52.4K |
|
704
TechnipFMC
FTI
$27.3B
| $1.89M | ﹤0.01% |
402,125
-20,563
| -5% | -$116K |
|
|
EXTN
705
DELISTED
Exterran Corporation
EXTN
| $1.87M | ﹤0.01% |
450,000
+190,000
| +73% | +$950K |
|
706
Tyson Foods
TSN
$20.6B
| $1.84M | ﹤0.01% |
30,955
-310,700
| -91% | -$19.2M |
|
707
Resideo Technologies
REZI
$3.95B
| $1.83M | ﹤0.01% |
166,121
+151,941
| +1,072% | +$1.92M |
|
708
Fate Therapeutics
FATE
$290M
| $1.76M | ﹤0.01% |
+44,000
| New | +$1.54M |
|
|
WLL
709
DELISTED
Whiting Petroleum Corporation
WLL
| $1.72M | ﹤0.01% |
+99,312
| New | +$5.53M |
|
710
American Airlines Group
AAL
$10.6B
| $1.63M | ﹤0.01% |
132,528
-339,794
| -72% | -$4.26M |
|
|
ZSAN
711
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.62M | ﹤0.01% |
28,571
| – | – |
|
|
CNR
712
Core Natural Resources Inc
CNR
$4.54B
| $1.57M | ﹤0.01% |
+353,955
| New | +$1.85M |
|
713
DraftKings
DKNG
$11B
| $1.47M | ﹤0.01% |
25,000
-435,000
| -95% | -$16.9M |
|
714
Annaly Capital Management
NLY
$17.1B
| $1.42M | ﹤0.01% |
50,000
+25,000
| +100% | +$724K |
|
715
Gran Tierra Energy
GTE
$335M
| $1.39M | ﹤0.01% |
600,000
| – | – |
|
716
Expro Ltd
XPRO
$1.91B
| $1.36M | ﹤0.01% |
146,808
| – | – |
|
717
Western Union
WU
$2.23B
| $1.31M | ﹤0.01% |
61,349
-91,924
| -60% | -$2.09M |
|
718
DaVita
DVA
$11.5B
| $1.31M | ﹤0.01% |
15,300
-86,600
| -85% | -$7.4M |
|
719
Columbus McKinnon
CMCO
$599M
| $1.3M | ﹤0.01% |
39,437
-160,563
| -80% | -$5.57M |
|
|
PDCE
720
DELISTED
PDC Energy, Inc.
PDCE
| $1.24M | ﹤0.01% |
+100,000
| New | +$1.42M |
|
|
ADNWW
721
DELISTED
Advent Technologies Holdings Warrant
ADNWW
| $1.22M | ﹤0.01% |
1,800,000
| – | – |
|
|
GDP
722
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $1.19M | ﹤0.01% |
154,743
| – | – |
|
723
Genuine Parts
GPC
$18.3B
| $1.11M | ﹤0.01% |
+11,659
| New | +$1.09M |
|
|
ZUO
724
DELISTED
Zuora, Inc.
ZUO
| $1.03M | ﹤0.01% |
+100,000
| New | +$1.16M |
|
725
Kinetik
KNTK
$3.69B
| $958K | ﹤0.01% |
172,410
-100,000
| -37% | -$640K |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.